Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference26 articles.
1. ANCA and predicting relapse in systemic vasculitis;Jayne;QJM,1995
2. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis;Nackman;J Am Soc Nephrol,1996
3. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangitis with renal involvement;Westman;J Am Soc Nephrol,1998
4. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients;Geffriaud-Ricouard;Clin Nephrol,1993
5. Serial managements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis;Kyndt;Am J Med,1999
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele;Modern Rheumatology Case Reports;2023-01-05
2. The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring;Clinical and Experimental Nephrology;2022-07-30
3. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange;CEN Case Reports;2019-10-14
4. Ruptured renal artery in microscopic polyangiitis: a case report and literature review;CEN Case Reports;2018-06-27
5. Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis;International Journal of Rheumatic Diseases;2017-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3